Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 10, 2019
Context: This filing serves as a Regulation FD disclosure to furnish presentation slides regarding the company's fiscal fourth quarter and full year results ended May 31, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached presentation slides (Exhibit 99.1) rather than the body of the 8-K report.
Material Changes
The filing does not detail specific material changes or comparative financial data within the text. It references the existence of presentation materials discussing the fiscal fourth quarter and full year ended May 31, 2019, but does not summarize the variances versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing presentation slides dated July 10, 2019, which discuss fiscal results. The text explicitly states that the information in these slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated July 10, 2019) for actual financial figures and management commentary.
- Verify that the presentation slides are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.
- Confirm the fiscal year-end date of May 31, 2019, when comparing results to other calendar-year companies.